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ABSTRACT 29 
Coenzyme A (CoA) biosynthesis is initiated by pantothenate kinase (PanK) and tissue CoA 30 
levels are controlled through differential expression and allosteric regulation of the PanK isoforms.  31 
Mutations in human PanK2 (hPanK2) cause a neurodegenerative disorder termed PKAN; however, 32 
PKAN neuropathology is not recapitulated in Pank2–/– mice.  The distribution of the PanK isoforms 33 
differed between human and mouse tissues with the relative expression of PanK2 being higher in 34 
human brain compared to mouse brain.  Comparative genomics analysis revealed that the 35 
acquisition of a mitochondrial targeting signal was limited to the PanK2 sequences from primates, 36 
and mouse PanK2 was localized in the cytosol.  Both human and mouse PanK2 possessed similar 37 
biochemical properties, responding to inhibition by acetyl-CoA and activation by 38 
palmitoylcarnitines.  Mouse brain had an abundance of the PanK2 allosteric activators, long-chain 39 
acylcarnitines, compared to liver, suggesting that the PanK2 isoform is more catalytically active in 40 
brain compared to liver.  CoA levels were the same in tissues from wild-type and Pank2–/– mice, 41 
and were highest in liver compared to brain and testes.  The differences in the tissue-specific 42 
expression and cellular localization of the mouse PanK2 compared to human PanK2 may account 43 
for the inability to recapitulate the neuropathology of PKAN disease in the mouse model.   44 
 45 
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INTRODUCTION 46 
CoA is an essential cofactor that plays a central metabolic role as the predominant acyl 47 
group carrier in living organisms (23).  The intracellular CoA levels vary depending on the 48 
metabolic state of the cell and are tightly controlled to allow coordination of major anabolic and 49 
catabolic pathways such as the tricarboxylic acid cycle and fatty acid metabolism (23,35).  50 
Regulation of the cofactor concentration is achieved through feedback inhibition of pantothenate 51 
kinase (PanK), the first enzyme in the biosynthetic pathway (28,29,34).  PanK catalyzes the ATP-52 
dependent phosphorylation of pantothenate (vitamin B5) to 4′-phosphopantothenate, and mammals 53 
express four catalytically active isoforms that have different sensitivities to inhibition by free CoA or 54 
CoA thioesters (30,40,41).  A fifth potential isoform, PanK4, lacks the essential catalytic glutamate 55 
residue present in all other enzymes (9) and is not a functional pantothenate kinase (39).  PanKs 56 
share a >80% identical catalytic core (10,30,40) attached to unrelated N-terminal extensions that 57 
range from a few residues in the case of PanK1β and PanK3 to ∼100-200 residues in the case of 58 
PanK1α and PanK2.  The N terminus of human PanK2 (hPanK2) directs it to the mitochondria.  59 
hPanK2 is sequentially processed twice to yield a stable 48 kDa mature protein (10,17,19).  The 60 
sequences adjacent to the cleavage sites at residues 31 and 140, implicate the mitochondrial 61 
processing peptidase in both cleavage steps.  A hPanK2 construct starting at Leu111 (42) lacks 62 
the first mitochondrial targeting signal, but is still processed and targeted to the mitochondria (17).  63 
Removal of both signals causes the enzyme to mislocalize to the cytosol (10,17).  A catalytically 64 
active hPanK2 inside the mitochondria was irreconcilable with the high organelle CoA 65 
concentration (13,37) until the discovery of palmitoylcarnitine as a positive regulator of hPanK2 66 
(22).  Palmitoylcarnitine releases the acetyl-CoA inhibition by competing for its binding site, and 67 
this regulatory mechanism activates hPanK2 when the mitochondrial demand for CoA is high for β-68 
oxidation.   69 
Pantothenate kinase-associated neudrodegeneration (PKAN) is a rare autosomal recessive 70 
disease caused by mutations in the PANK2 gene (7,42).  PKAN patients exhibit pathological 71 
accumulation of iron in the brain, movement and speech defects and, in some cases, pigmentary 72 
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retinopathy (7,8,42).  The classic form of the disease appears in childhood and is characterized by 73 
a relentless progression of dystonia, dysarthria and rigidity.  The classical disease is more 74 
frequently associated with mutations that abolish or severely impair hPanK2 activity.  The atypical 75 
form of PKAN has a later age at onset and a slower progression of speech-related and psychiatric 76 
symptoms.  Some hPanK2 mutations result in protein misfolding or in truncated proteins; however, 77 
others give rise to proteins with wild-type or significant residual catalytic activity (19,41).  Active 78 
hPanK2 mutants exhibit the same regulatory properties and localization as the wild-type enzyme 79 
(19,22,41), raising the question of what hPanK2 function is compromised by these mutations.  To 80 
further complicate the picture, the connection between CoA biosynthesis/metabolism, 81 
neurodegeneration and brain iron accumulation remains unclear.  Reduced phosphorylation of 82 
pantothenate may cause accumulation of cysteine, a CoA precursor, in regions of the brain that 83 
are normally rich in non-heme iron.  Cysteine oxidation in the presence of iron would then result in 84 
free radical production and cell damage (17,42).  Alternatively, oxidative stress caused by reduced 85 
CoA-dependent energy production may selectively impact those tissues like the retina and the 86 
brain characterized by a high metabolic demand and sensitivity to oxidative damage (7).  There is 87 
a growing body of evidence supporting the role of mitochondria in the pathogenesis of several 88 
neurodegenerative diseases.  Alzeihmer’s, Parkinson’s and Huntington’s share common 89 
neurological features with PKAN (3,21,32,33) and mitochondrial defects lead to retinal 90 
degeneration (4,31,38) and male sterility (24,25).   91 
A significant conundrum in the field is that the Pank2 knockout mice do not recapitulate the 92 
neurological abnormalities that characterize the human phenotype, although they do exhibit retinal 93 
degeneration and male sterility (20). We addressed this issue by comparing the tissue distribution, 94 
gene structure, biochemical properties and subcellular localization of mPanK2 and hPanK2.  95 
Although the biochemical regulatory properties of the two enzymes are indistinguishable, 96 
differences in gene structure, subcellular localization of the proteins and relative abundance of 97 
PanK2 in human and murine tissues suggest rationales for the similarities and differences in the 98 
PKAN patients and Pank2 knockout mice. 99 
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MATERIALS AND METHODS 100 
Materials.  Materials were purchased from the following suppliers: oligonucleotides and 101 
probes from the Hartwell Center at the St. Jude Children’s Research Hospital; Poly(A)+ RNAs from 102 
mouse and human brain sections, human liver, brain and testes from Clontech; molecular biology 103 
reagents from Qiagen; restriction enzymes and T4 DNA ligase from Promega; SuperScript™ II 104 
RNase H- reverse transcriptase, TRIZOL reagent, pCR2.1 and pcDNA3.1 vectors from Invitrogen; 105 
Real-time PCR mix from Applied Biosystems; Bradford dye-binding protein assay solution from 106 
Bio-Rad; D-[1-14C]pantothenate (specific activity, 55 mCi/mmol) from American Radiolabeled 107 
Chemicals and [1-14C]lauric acid (specific activity 55 mCi/mmol) from GE Healthcare.  All other 108 
reagents were of analytical grade or better and were obtained from Sigma Chemical Co.  109 
Generation of Pank2 knockout mice.  The targeting construct pPJ259 was generated by 110 
cloning 3 fragments of mouse Pank2 genomic DNA into vector pNEOtkLoxP.  pPJ259 contained a 111 
loxP site between a 3.5-kb genomic DNA and the TK and NEO selection cassettes, followed by a 112 
second loxP site upstream of a 2.8-kb genomic DNA fragment containing exon 3, and by a third 113 
one upstream of a 1.8-kb genomic DNA containing exon 4 (Fig. 1A).  DraIII was used to linearize 114 
the targeting vector prior to transfection into the embryonic stem cell lines derived from 129/SVEV 115 
(Specialty Media), grown on mitotically inactivated mouse embryonic fibroblasts which carry 116 
resistance to neomycin.  Clones resistant to G418 were selected and screened by Southern blot 117 
analysis using a 772-bp probe corresponding to a genomic DNA region outside the targeted 118 
portion.  Genomic DNA (10 μg) from individual ES cell clones was digested with BamHI and 119 
Southern blot analysis was carried out as previously described (15).  The presence of the third 120 
loxP site was confirmed by PCR analysis.  ES cells containing the recombined Pank2 DNA at the 121 
correct locus were injected into C57BL/6J blastocysts, which were then implanted into 122 
pseudopregnant female mice by the St. Jude Transgenic Core Facility.  Male offspring with 75 to 123 
90% agouti color, the coat color contributed by the ES cells, were bred with C57BL/6J females.  124 
Pups that were 100% agouti, indicating germ line transmission, were screened.  Tail clips were 125 
lysed and multiplex PCR analysis was used to genotype the mice using RED Extract-N-Amp PCR 126 
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kit (Sigma) and three primers: F (TTCCCTGCTTAGGTAGGATTGC), R1 127 
(CCTTTGGACACCATGTAAATGAAC) and T (CCAAGTTCGGGTGAAGGC).  The wild type allele 128 
yielded a product of 618 bp, and the allele with the recombined Pank2 yielded a product of 452 bp.  129 
FVB/N-Tg(ACTB-cre)2Mrt/J mice expressing Cre recombinase under the human β-actin gene 130 
promoter were utilized to generate complete deletion of Pank2 by recombination of the first and 131 
third loxP sites, resulting in the deletion of exon 3.  A multiplex PCR analysis was used to genotype 132 
the offsprings from the breeding of ACTB-cre mice with mice heterozygous for the recombined 133 
Pank2 using primers F, R1 and R2 (CCTCAACTCCTAGATCCAAACTG).  A 618 bp product 134 
indicated the presence of a wild type allele, and a 526 bp product indicated the presence of a 135 
knockout allele.  Heterozygous mice for Pank2 knockout were bred to generate homozygous 136 
knockout mice. 137 
Real time qRT-PCR analysis.  Total RNA was either purchased (mouse and human brain 138 
sections, human liver, brain and testes) or isolated from whole brain and caudate nucleus region, 139 
whole liver and testes of 2-3 wild type and Pank2–/– mice, using the TRIZOL reagent according to 140 
the manufacturer’s instructions.  Pelleted RNA was resuspended in nuclease-free water, digested 141 
with DNase I to remove any contaminating genomic DNA, aliquoted, re-precipitated in ethanol and 142 
stored at –20°C.   143 
Synthesis of first-strand cDNA was obtained by reverse transcription using SuperScript™ II 144 
RNase H- reverse transcriptase, the RNA templates and random primers.  Quantitative real-time 145 
PCR of the human and murine PanK isoforms in each sample was performed in triplicate using the 146 
ABI Prism® 7700 Sequence Detection System using primers and probes listed in Table 1.  The 147 
Taqman Human GAPDH and Rodent GAPDH Control Reagents (Applied Biosystems) were the 148 
source of the primers and probes for quantitating the control GAPDH mRNA.  All of the real-time 149 
values were compared using the CT method, and the amount of cDNA (2–ΔCT) was reported relative 150 
to GAPDH.   151 
Cloning of the murine Pank2, dell transfection and preparation of cell lysates.  A 1.6 152 
kb fragment encoding the long form of mPanK2 (10) was assembled from 3 ESTs (NCBI accession 153 
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numbers BG091057, CB247865 and BQ715345) and ligated into pcDNA3.1+ between EcoRI and 154 
XbaI restriction sites.  The resulting vector was named pPJ256.   155 
HEK 293 and 293T cells were cultured in Dulbecco’s modified Eagle’s medium containing 156 
10% fetal bovine serum (Atlanta Biologicals) and transfected with FuGENE 6 (Roche Applied 157 
Science), as per manufacturer’s instructions.  For biochemical assays, 293T cells were transiently 158 
transfected for 48 h with pPJ256 and pKM56, a pcDNA3.1-derived vector encoding the mature 159 
hPanK2 (residues 141-570) (41).  For immunofluorescence analysis, 293 cells were stably 160 
transfected with pPJ256 and pKM4, a pcDNA3.1-derived vector encoding the mitochondrial 161 
precursor hPanK2 (residues 1-570) (41), by selection in growth medium containing 600 μg/ml of 162 
G418.  Individual colonies were then expanded and screened for expression by western blotting 163 
(see below).  Transfected cells were collected, washed with PBS, and resuspended in lysis buffer 164 
(10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 10 mM NaF, and 5 μg/ml of leupeptin).  After incubation on 165 
ice for 1 h, cells were lysed by sonication.  The lysate was centrifuged at 5,000 × g for 5 min at 4°C 166 
to remove the unbroken cells.  The supernatant was then either loaded on SDS-PAGE gels for 167 
western blotting analysis or mixed with an equal volume of saturated ammonium sulfate for 168 
subsequent activity assays.  After incubation on ice for 1 h, the protein precipitate was collected by 169 
centrifugation at 3,000 × g for 30 min.  The precipitated protein was resuspended in the lysis buffer 170 
without leupeptin and dialyzed against the same lysis buffer overnight at 4°C.  The dialyzed protein 171 
sample was stored in 50% glycerol at –20°C. 172 
Western blot detection and immunofluorescence.  Peptides corresponding to protein 173 
stretches unique to mPanK2 (GESADSEARRRDPLRRR) and hPanK2 (EGRRQEPLRRRASSASV) 174 
were synthesized and coupled to keyhole limpet hemocyanin by the Hartwell Center for 175 
Biotechnology, St. Jude Children’s Research Hospital, and sent to Rockland Inc. (Gilbertsville, PA) 176 
to raise rabbit polyclonal antisera.  Affinity purification of the polyclonal antibody was performed as 177 
previously described (14,30).  Heavy mitochondrial and cytosolic brain fractions (200 μg) were 178 
loaded on 8% SDS-PAGE gels and the resolved proteins were electroblotted onto a polyvinylidene 179 
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difluoride membrane.  The lysate from stably transfected cells (5 μg) was mixed with the same 180 
amount of cytosolic brain fraction from Pank2 knockout mice and used as mPanK2 controls.  181 
mPanK2 was detected by the mPanK2 antibody at a concentration of 0.1 μg/ml.  Horseradish 182 
peroxidase-conjugated protein A was used as the secondary antibody at a dilution of 1:5,000.  The 183 
membranes were then stripped using a western blot recycling kit (Alpha Diagnostic International) 184 
and reprobed with antibodies against the mitochondrial marker pyruvate dehydrogenase (PDH, E2 185 
subunit, Molecular Probes) and the cytosolic marker β-actin (Sigma) used at concentrations of 2.5 186 
μg/ml and 5 μg/ml, respectively, using horseradish peroxidase-conjugated anti-mouse IgG (GE 187 
Healthcare) as secondary antibody at a dilution of 1:5,000.  The immuno complexes were detected 188 
using the ECL kit (GE Healthcare). 189 
The localization of mPanK2 and the mitochondrial precursor hPanK2 was determined by 190 
confocal microscopy, performed by the Scientific Imaging Shared Resource at St. Jude Children’s 191 
Research Hospital using a Zeiss LSM 510 META multiphoton microscope equipped with a Plan-192 
Neofluor 100x/1.3 oil immersion objective and controlled by Laser Scanning Microscope LSM 510 193 
software (Ver.3.2, Carl Zeiss GmbH, Germany).  Sample slides were prepared as described below 194 
and washed with PBS between each incubation step.  HEK 293 cells stably transfected with 195 
pPJ256 and pKM4 were seeded in chamber slides (Lab-Tech II, Nalge Nunc International) and 196 
allowed to adhere and grow for 16-24 h before being incubated with 250 nM MitoTracker red 197 
CMXRos (Molecular Probes) for 30 min at 37°C.  Cells were then fixed with 3.7% formaldehyde for 198 
15 min at 37°C and permeabilized with 0.2% Triton X-100 for 5 min, before being incubated with 199 
the mPanK2 and hPanK2 antibodies at concentrations of 0.03 and 0.005 μg/ml, respectively, for 1 200 
h at room temperature.  Anti-rabbit IgG conjugated to Alexa Fluor 488 (Molecular Probes) diluted 201 
1:250 was then added to the cells, followed by 1 h incubation at room temperature.  The slides 202 
were finally washed with PBS and mounted with ProLong Gold antifade reagent with DAPI 203 
(Molecular Probes).   204 
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Liver and brain fractionation.  Heavy mitochondria were isolated from wild type and 205 
Pank2 knockout mice liver or brain as described by Graham (6).  All centrifugation steps and 206 
fraction manipulation were conducted at 4°C.  Briefly, freshly harvested organs from 4 wild type or 207 
knock-out mice (∼4 g) were homogenized in 12 ml of ice-cold LHM buffer (10 mM Hepes-KOH, pH 208 
7.4, 0.2 M mannitol, 50 mM sucrose, 10 mM KCl and 1 mM EDTA) using a tissue grinder with a 209 
motorized Teflon pestle (Glas-Col).  The homogenate was centrifuged at 1,000 × g for 10 min to 210 
remove nuclei, unbroken tissue and other cell debris.  The supernatant was further centrifuged at 211 
3,000 × g for 10 min and the pellet, consisting of heavy mitochondria, was washed twice with 10 ml 212 
of LHM buffer, gently resuspended in 0.5 ml of the same buffer using a Dounce homogenizer and 213 
finally aliquoted and stored at –80°C.  The 3,000 × g supernatant was then sequentially centrifuged 214 
at 12,000 × g for 15 min and 105,000 × g for 60 min to remove the light mitochondrial pellet and 215 
microsomes, respectively.  The resulting supernatant represented the cytosolic fraction.   216 
CoA measurements.  Extraction of CoA species from mouse whole tissues or liver 217 
fractions and CoA assay were performed as described by Knights and Drew (18) with some 218 
modifications.  For whole liver, brain and testes, ∼100 mg of tissue were homogenized in 0.4 ml of 219 
chilled 6% HClO4 containing 28 mM DTT.  For liver fractions, 12 mg of mitochondrial or cytosolic 220 
protein were mixed with an equal volume of 12% HClO4 containing 56 mM DTT.  The precipitated 221 
proteins were removed by centrifugation and the pellet put aside for quantitation of long-chain CoA 222 
thioesters.  The supernatant was divided into two aliquots; one aliquot was adjusted to pH 7.5-8.5 223 
with 2 M KOH and centrifuged to remove the insoluble potassium perchlorate formed, then used to 224 
measure the amount of free CoA.  The second aliquot was adjusted to pH 11-12 with 1 M KOH, 225 
incubated for 1 h at room temperature to hydrolyze the short-chain CoA thioesters, then 226 
neutralized with 0.6 M HCl and centrifuged.  The supernatant was extracted 3 times with an equal 227 
volume of hexane and the aqueous phase saved to determine the sum of free and short-chain 228 
CoAs.  The pellet containing the long-chain CoA thioesters from the first centrifugation step was 229 
first washed with 0.6% perchloric acid containing 5 mM DTT, then with 5 mM DTT and finally 230 
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resuspended in the same solution.  The CoA thioesters were hydrolyzed to free CoA and extracted 231 
as described above.  The reaction mixture for the CoA assay contained 200 mM Tris-HCl (pH 7.5), 232 
8 mM MgCl2, 0.1% Triton X-100, 2 mM EDTA, 20 mM NaF, 2.5 mM ATP, 10 μM [1-14C]lauric acid, 233 
100 ng of E. coli acyl-CoA synthetase (0.0863 U) and extracts containing 25-400 pmol of free CoA, 234 
in a total volume of 100 μl.  The reaction was initiated by the addition of the enzyme, and the 235 
reaction mixture was incubated at 35°C for 30 min, followed by the addition of 325 μl of 236 
methanol:chloroform:n-heptane (1.41/1.25/1, v/v/v) and 25 μl of 0.4 M acetic acid.  After the 237 
mixture was mixed vigorously and centrifuged, [1-14C]lauryl-CoA in upper aqueous phase was 238 
quantitated by counting in 3 ml of ScintiSafe 30% using Beckman LS 6500.  The amount of free 239 
CoA, short-chain and long chain acyl-CoA were combined and expressed as nmoles of total CoA/g 240 
of wet tissue or nmoles of total CoA/g of protein in the case of liver mitochondrial and cytosolic 241 
fractions. 242 
Acylcarnitine measurements.  Specimens of powdered liver and brain from wild type and 243 
Pank2–/– mice were homogenized in deionized water, and tissue extracts were prepared as 244 
previously described  (2,16).  Measurement of acylcarnitines was done by direct-injection 245 
electrospray tandem mass spectrometry, using a Quattro Micro LC-MS system (Waters-246 
Micromass) equipped with a model HTS-PAL autosampler (Leap Technologies), a model 1100 247 
HPLC solvent delivery system (Agilent Technologies) and a data system running MassLynx 248 
software. 249 
Pantothenate kinase activity assay.  The lysates of transfected HEK 293T cells were 250 
obtained and treated as described above prior to measuring the pantothenate kinase activity (41).  251 
In particular, the reaction mixtures contained 45 μM D-[1-14C]pantothenate (specific activity 27.5 252 
mCi/mmol), 250 μM ATP pH 7.0, 10 mM MgCl2, 0.1 M Tris-HCl pH 7.5 and 5 μg of protein.  The 253 
inhibitory effect of acetyl-CoA on the activity of mPanK2 and mature hPanK2 was determined by 254 
including increasing concentrations of the compound in the reaction mixtures, as indicated.  To 255 
investigate the effect of palmitoylcarnitine on the acetyl-CoA inhibition, mPanK2- and hPanK2-256 
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containing lysates were incubated with 62.5 and 93.8 nM of inhibitor, respectively, and increasing 257 
concentrations of palmitoylcarnitine, as indicated.  The residual pantothenate kinase activity in 258 
PanK2 knockout mice liver and brain cytosolic fractions was measured in reaction mixtures 259 
containing 45 μM D-[1-14C]pantothenate, 2.5 mM ATP pH 7.0, 10 mM MgCl2, 0.1 M Tris-HCl pH 260 
7.5, increasing amounts of protein, as indicated, and incubated for 15 min at 37°C.  The activity of 261 
the correspondent wild type fractions was determined in parallel under the same conditions. 262 
Bioinfomatic analysis.  Genomic sequences for human (chromosome 20, NT_011387.8), 263 
chimpanzee (chromosome 20, NW_001230484), cow (chromosome 13, NW_001493148.1), dog 264 
(chromosome 24 NW_876277.1), cat (no chromosome information, AANGO1231943.1) and 265 
mouse PanK2 (chromosome 2, NW_000178.1) were retrieved from NCBI.  The macaque genomic 266 
sequence was retrieved from the sequencing center’s website 267 
(http://www.hgsc.bcm.tmc.edu/projects/rmacaque/).  Sequence comparisons were performed using 268 
the VISTA tools for comparative genomics (http://genome.lbl.gov/vista/index.shtml) (5). 269 
 270 
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RESULTS 271 
Generation of Pank2 knockout mice.  PanK2 knockout mice were first generated by 272 
insertion of a selection cassette and disruption of the Pank2 coding sequence (20).  We 273 
independently derived Pank2-deficient mice by deletion of a 2.8 kb DNA fragment containing exon 274 
3 (Fig. 1A).  Cre recombinase-dependent recombination of the first and third loxP sites resulted 275 
also in the removal of the selection cassette along with exon 3.  Embryonic stem cells were 276 
transfected and selected, and chimeric mice were generated and bred by standard procedures 277 
described under “Materials and Methods.”  Mice heterozygous for Pank2 were identified by PCR 278 
analysis of tail DNA and bred to produce homozygous knockout mice (Fig. 1B).  A reproductive 279 
defect in the male PanK2-deficient mice precluded establishment of a homozygous breeding 280 
colony, and routine mating of heterozygotes and genotyping of the pups was necessary to 281 
propagate the Pank2–/– mice.  The testis phenotype of the knockout mice generated by deletion of 282 
the Pank2 gene was the same as described previously (20).  Measurement of the testes weight 283 
and histological analysis revealed significantly smaller testes and the absence of elongated mature 284 
spermatozoa in the seminiferous tubules of these Pank2 knockout mice (data not shown).  Our 285 
Pank2–/– mice did not show a significant difference in weight at 6-8 weeks of age compared to 286 
littermate controls.   287 
Tissue distribution of murine and human PanK isoforms.  A considerable number of 288 
PKAN-causing PANK2 mutations completely abolish hPanK2 enzymatic activity as a result of 289 
frameshifts and premature stops in the enzyme sequence (8,42).  Similarly, deletion of the mouse 290 
Pank2 exon 3 resulted in loss of enzymatic activity (see below).  In spite of this, only retinal 291 
degeneration is common between some of the PKAN patients and Pank2 knockout mice, while the 292 
neurodegeneration is unique to humans and the knockout mice exhibit azoospermia (20).  We 293 
compared the mRNA expression levels of the murine and human PanK isoforms in brain, testes 294 
and in liver by quantitative RT-PCR.  Expression of PanK4 was not taken into account because it 295 
does not exhibit PanK activity (39).  PANK1 transcripts (PANK1α + PANK1β) dominated human 296 
liver, whereas Pank1 transcripts (Pank1α + Pank1β) in mouse liver were equivalent to Pank3 297 
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transcripts (Fig. 2) and relatively lower than in human.  PANK2 transcripts, on the other hand, were 298 
relatively higher than PANK1 and equivalent to PANK3 in human brain, whereas Pank2 transcripts 299 
were low in mouse brain and Pank3 expression was highest.  Pank2 transcripts were extremely 300 
high in mouse testis, but were considerably less abundant in human testis.  The ratio between 301 
mouse Pank2 and Pank3 mRNAs was estimated at approximately 1:2 in brain and 1:1 in testes, 302 
with Pank2 representing 34% and 46% of the expressed isoforms in the two tissues, respectively 303 
(Fig. 2A).  Human PANK2 transcripts were high in brain, equivalent to PANK3, and represented 304 
45% of the PANK transcripts.  Only 21% of the PanKs expressed in human testes were the PANK2 305 
isoform (Fig. 2B).  A detailed analysis of specific areas of the brain revealed a high expression of 306 
human PANK2 transcripts in the cerebellum, which controls motor coordination and movement, 307 
and, as previously reported, in the caudate nucleus (10) (Fig. 2D).  The overall abundance of the 308 
murine Pank transcripts was lower than what was measured in the corresponding human brain 309 
fractions (Fig. 2C), but the level of Pank2 was higher in the cerebellum and cerebral cortex 310 
compared to whole brain.  These data revealed a correlation between the predominance of PanK2 311 
expression and the physiological impact of loss of expression in tissues from human and mouse.   312 
PanK isoform expression and tissue CoA levels in wild-type and Pank2 knockout 313 
mice.  Loss of Pank2 expression did not result in increased expression of either Pank1 or Pank3 in 314 
the brain, testes or liver of Pank2–/– mice (data not shown).  Measurements of the CoA content 315 
revealed that brain and testes from adult wild type mice contained 19 and 26 nmoles of total CoA 316 
per gram of wet tissue, respectively, while the liver content was 6-fold higher (Fig. 3A).  In each 317 
tissue, 80-90% of the CoA pool was unesterified or “free.”  No significant difference in the total or 318 
free CoA content was found between organs from wild type and age-matched Pank2 knockout 319 
mice, indicating that the remaining PanK isoforms were able to maintain the CoA levels, even in 320 
mouse testes.  The CoA levels in mitochondria or cytosol also were the same in mouse wild-type 321 
and knockout tissues, as exemplified by liver (Fig. 3B).  These data indicated that loss of PanK2 322 
expression did not reduce the CoA content, and that the activities of the PanK1 and PanK3 323 
enzymes supplied the cellular CoA requirements of most cell types.   324 
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Biochemical properties of mPanK2 and tissue acylcarnitine measurements.  The 325 
mature hPanK2 (residues 141-570, 47.4 kDa) is similar to the predicted size of mPanK2 (48.6 326 
kDa).  The N-terminus of the full length mPanK2 is 122 residues shorter than the full-length human 327 
homolog, therefore we compared the regulatory properties of mPanK2 and the mature hPanK2 328 
expressed in the lysates of transfected HEK 293T cells.  We found that the two enzymes were 329 
similarly inhibited by acetyl-CoA and de-inhibited by palmitoylcarnitine (Fig. 4).  The acetyl-CoA 330 
IC50s were estimated at 125 nM for hPanK2 and 62.5 nM for mPanK2, with slight variations from 331 
preparation to preparation, and the concentration of pamitoylcarnitine that maximally restored the 332 
activity was approximately 8 μM in both cases (Figs. 4A and 4B).  Free carnitine and short-chain 333 
acylcarnitines are not activators of hPanK2 (22), and the latter species were the major components 334 
of the acylcarnitine pool in mouse liver obtained from animals fed standard chow (Fig. 6B).  335 
Conversely, the mouse brain contained significantly higher amounts of myristoyl, palmitoyl, stearyl 336 
and oleoylcarnitine (Fig. 5A).  Organs from wild-type or Pank2 knockout mice had comparable 337 
acylcarnitine distributions (Fig. 5).  Taken together, these data indicated that hPanK2 and mPanK2 338 
had the same biochemical properties in humans and mice and pointed out that the contribution of 339 
PanK2 to the total PanK activity in a specific tissue would depend on the molar ratio of inhibitors 340 
and activator(s).   341 
Bioinformatic analysis of mammalian PanKs and localization of mPanK2 in stably 342 
transfected cells and brain fractions.  The complete coding sequence and the intron-exon 343 
organization of the human PANK2 gene was elucidated by Hörtnagel and coworkers (10) who 344 
found an ATG start codon upstream of the CTG codon originally proposed as the start of the 345 
hPanK2 coding sequence (42).  The N-terminus of the full length hPanK2 protein contains a 346 
mitochondrial targeting sequence (residues 1-140), which is responsible for the subcellular 347 
localization of the enzyme and is encoded by exon 1.  We compared the corresponding nucleotide 348 
sequences from six organisms (humans, macaques, cows, dogs, cats and mice) using the VISTA 349 
tools for comparative genomics (Fig. 6).  The analysis revealed that while the macaque sequence 350 
encoded an intact mitochondrial targeting sequence, most of the aligned nucleotide regions from 351 
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mouse, cat, dog and cow were not translated due to the presence of in-frame stop codons or the 352 
absence of earlier start codons.  In spite of the sequence similarity, the predicted ATG start codon 353 
in these organisms corresponded to residue 123 of hPanK2, thus excluding most of the 354 
mitochondrial targeting sequence.  The targeting sequence was also found in the predicted 355 
chimpanzee PanK2 protein (NCBI accession number XP_001163366), which was not included in 356 
the VISTA analysis because of the poor quality of the DNA data in the region aligned.  These data 357 
suggest that emergence of a mitochondrial targeting sequence occurred following the divergence 358 
of primates.  359 
The bioinformatics data prompted us to re-examine the subcellular localization of hPanK2 360 
and mPanK2.  Stable cell clones overexpressing the full-length forms of hPanK2 and mPanK2 361 
were generated, and the localization of the two proteins was investigated in situ by confocal 362 
immunofluorescence microscopy using mPanK2- and hPanK2-specific antibodies.  Unlike the 363 
mitochondrial hPanK2 (Fig. 7, E-H), mPanK2 was found in the cytosol (Fig. 7, A-B).  These results 364 
were the same in either the human cell line, HEK 293T (Fig. 7), or the mouse cell line, NIH 3T3 365 
(data not shown).  The subcellular location of mPanK2 was confirmed by western blotting analysis 366 
of cytosolic and mitochondrial fractions obtained from wild-type and knockout mouse brains and 367 
livers using the mPanK2-specific antibody, along with antibodies that recognize the β-actin marker 368 
protein for cytosol and the pyruvate dehydrogenase marker for mitochondria (Fig. 8A).  mPanK2 369 
was found exclusively in wild type cytosol, not in mitochondria, and the size of the endogenous 370 
protein matched the size of the full-length expressed mPanK2 predicted from genomic analysis 371 
(48.6 kDa).   372 
To corroborate these results, we measured the total PanK activity in the cytosol and heavy 373 
mitochondrial fractions isolated from mouse brain and liver.  PanK activity was detected in the 374 
cytosolic (Fig. 8A), but not in the mitochondrial fractions.  The PanK enzymatic assay cannot 375 
discriminate between the various isoforms, but comparison of the cytosolic activity from wild-type 376 
and knockout mice showed a 10- and 2-fold reduction in knockout brain and liver, respectively, 377 
under the conditions described under Materials and Methods.  The residual PanK activity in 378 
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knockout brain and liver was due to the expression of the PanK1 and PanK3 isoforms, and 379 
knockout brain showed a greater decrease in activity, consistent with the higher relative 380 
abundance of mPanK2 in wild-type brain (32%) compared to liver (9%) (Fig. 2A).  The total PanK 381 
enzymatic activity in wild-type brain was almost as high as in liver, despite somewhat lower PanK 382 
expression levels (Fig. 2A), and showed a greater proportional decrease in the knockout brain, 383 
indicating a greater PanK2 contribution in this tissue, possibly due to a higher concentration of 384 
long-chain acylcarnitine activators (Fig. 5A).   385 
 386 
DISCUSSION 387 
A major finding of this study is that mouse PanK2 is a cytosolic protein in contrast to the 388 
mitochondrial localization of the human enzyme.  The PanK2 proteins from human and mouse are 389 
homologous due to the strong similarity between their catalytic cores, and accordingly their 390 
biochemical and regulatory properties are similar.  Both proteins are equivalently sensitive to 391 
feedback inhibition by acetyl-CoA, which is relieved by long-chain acylcarnitine (Fig. 4)(22).  The 392 
amino terminal sequences of the PanK2s from human and mouse are distinctly different; however, 393 
and the mouse protein does not localize to the mitochondria (Figs. 7 and 8).  In contrast to 394 
hPanK2, the analysis of the mPanK2 sequence with PSORTII (11) does not indicate a 395 
mitochondrial localization for the enzyme, but rather it is predicted to localize to the cytosol.  The 396 
cytosolic location of mPanK2 was directly observed using in situ microscopy of stably expressed 397 
protein and was confirmed by subcellular fractionation of the endogenous PanK2 in mouse brain 398 
and liver (Figs.7 and 8).  mPanK2 is not processed and the molecular size of mPanK2 in vivo 399 
corresponds to the size predicted by expression from the first in-frame Met codon (48.6 kDa), 400 
rather than an upstream Leu codon (50.2 kDa) that was initially proposed as the start site (17).  401 
These data are not in agreement with previous reports that concluded both mouse and human 402 
PanK2 proteins as associated with mitochondria based on the immunolocalization of hPanK2 and 403 
mPanK2 in transiently transfected COS7 cells and tissue sections.  However, our examination of 404 
the same data suggest a significant difference between the localization of the two proteins (17,20).  405 
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Analysis of the PanK2 protein sequences from available mammalian genomes shows that only 406 
primates evolved the mitochondrial targeting mechanism, suggesting that this feature is related to 407 
the more complex neurological development in primates. 408 
These results provide a rationale for why the phenotype of the Pank2 knockout mouse does 409 
not include an overt neurological disease that is characteristic of PKAN patients, including those 410 
with null mutations in the PANK2 gene (20).  The possibility of interference of the gene insertion 411 
cassette on the transcriptional activity of flanking chromosomal regions was ruled out by the 412 
independent isolation of a Pank2–/– mouse using a gene deletion strategy that removed the 413 
selection cassette as well as exon 3.  The loss of mPanK2 activity in Pank2–/– mice is not 414 
accompanied by an increase in the expression level of the other isoforms, and does not lead to 415 
decreased CoA levels in brain, liver or testes.  These data indicate that the other PanK isoforms 416 
are able to maintain the homeostatic cofactor concentration in most tissues of the knockout 417 
animals.  This outcome is not completely unexpected since all PanKs are regulated through 418 
feedback inhibition by CoA thioesters and a drop in the inhibitor levels would stimulate the activity 419 
of the remaining isoforms.  However, the fact that the Pank2 knockout mice exhibit a defect in 420 
sperm maturation suggests cell-type specific isoform expression has a selective effect on 421 
development of selected lineages.  No data are available on the CoA content in normal and PKAN-422 
affected brains, although like the mouse testis, these data may not reveal deficiencies in 423 
specialized cell types.  There was a correlation between the relative abundance of PanK2 424 
transcripts and the tissue-specific dysfunction related to the loss of its expression.  Mouse PanK2 425 
constituted a smaller proportion of the mRNA species in most brain regions compared to the 426 
predominant expression of hPanK2 in human brain.  In particular, the human caudate nucleus, 427 
which is part of the basal ganglia where iron accumulation is noted in many PKAN patients (36), 428 
has a high proportion of PANK2 transcripts, whereas the mouse caudate nucleus has a relatively 429 
lower amount (Fig. 2C).  On the other hand, Pank2 expression is high in mouse testes (Fig. 2A), 430 
where loss of its expression impacted the development of spermatozoa in the knockout animals.     431 
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The intramitochondrial concentration of CoA species is estimated to be in the millimolar 432 
range, thousands of fold higher than what would inhibit the PanK2 enzymes (13,37).  Carnitine is 433 
also an abundant metabolite (12) and this pool is made up of free carnitine, short- and long-chain 434 
carnitine esters.  Compositional analysis of the acylcarnitines present in mouse liver and brain 435 
revealed a higher long-chain to short-chain ratio in the brain, suggesting that in non-stressed 436 
conditions on a standard diet, the basal activity of mPanK2 is higher in brain due to the higher 437 
concentration of activator.  The ratio of free carnitine to acylcarnitine varies also as a function of 438 
the availability of fatty acids destined for β-oxidation and energy production (26,27).  The cytosolic 439 
location of mPanK2 would not prevent its activation by acylcarnitine, but also would not optimize 440 
the response.  In the absence of PanK2 expression, a prompt response to the mitochondrial 441 
demand for CoA may not be satisfied, potentially disrupting or delaying the function of the 442 
organelle, particularly in human neural tissue where the PanK2 is highly expressed and localizes to 443 
the site of palmitoylcarnitine synthesis.  We recently proposed a model that places hPanK2 in the 444 
intramembrane space (22), the submitochondrial compartment where palmitoyl-CoA is converted 445 
to palmitoylcarnitine; the high local concentration of palmitoylcarnitine would efficiently activate 446 
hPanK2 making the enzyme a more sensitive sensor of the mitochondrial demand for CoA.  447 
However, because palmitoylcarnitine diffuses into the cytosol, the same sensory mechanism would 448 
work even if the enzyme is localized in this compartment, as is the case with mPanK2 and all other 449 
metazoan PanKs, with the exception of primates.  Therefore, our working hypothesis is that the 450 
biochemical function of mPanK2 and hPanK2 is the same and does not strictly require 451 
mitochondrial localization. 452 
Chemical knockout of the total PanK activity dramatically reduces CoA levels in liver and 453 
significantly affects mitochondrial function and morphology (39).  Reduction or elimination of 454 
PanK2 activity in PKAN patients results in neurological symptoms that are common to several 455 
other neurodegenerative disorders associated with mitochondrial dysfunction (21,32,33).  This 456 
correlation between potential mitochondrial dysfunction and hPanK2 activity has been attributed to 457 
the unique localization of hPanK2 (10,19).  However, defects in mitochondrial respiration or 458 
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alteration of the transmembrane potential can also be the underlying cause of the male sterility and 459 
retinal degeneration (4,24,25,31,38) observed in the Pank2 knockout mice (20) and the fumble fly 460 
(1), both of which are deficient in a cytosolic enzyme.  Thus, it appears that this correlation is not 461 
linked to the specific localization of PanK2.  Instead, knocking out of a PanK isoform would likely 462 
cause a mitochondrial dysfunction-related phenotype in cell types where the expression of one 463 
isoform predominates and the corresponding reduction in CoA level is less likely to be restored by 464 
the activation of the remaining isoforms.   465 
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 579 
TABLE I 580 
Primers and Probes for mouse and human PanK RT-PCR 581 
 582 
Gene Forward Primer (5′-3′) Reverse Primer (5′-3′) Probe (5′-3′)1 
Pank1 ATGACTTGCCCTCATTTGCAT TGGGAGCCCCTCCAAATT CCGTATGAAGGGCAGCAAACCC 
Pank2 TTGGGCATACGTGGAGCTTT TCTCACATACATTTCAACAGGACAAG TGGACTCCCACCAGCAGCTGAC 
Pank3 CTAAGGAACGCCTGCCATTC CTTTGGTTCCCAGTGACAGACA AGCTGATCCAGAAACCGCAGTCA 
PANK1 TGAGCTTATTGTTGAAAGGGATTTT GGTGCTCAGAAGGCAGAGAAA 
AGGACAGAACAATTACTCCATGAT
GAATCTTC 
PANK2 AGAGCTGCTCTGTGTTCAGTTGA CGCATAGTAGCCTGCCTTACATT 
AGCAAGTTCAAACAGGACACAAAA
CCA 
PANK3 CACCATGCTCTTATCTCGCACTT TTGAAGGCAGAGGGCTCAAC TCCCCTTGCCTGAATCTGG 
1All probes used 6-FAM (6-carboxyfluorescein) as reporter and BHQ1 (black hole quencher 1) as 583 
quencher. 584 
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FIGURE LEGENDS 585 
FIG. 1.  Generation of Pank2 knockout mice by homologous recombination and cre-586 
mediated deletion.  (A) Organization of the Pank2 locus and screening strategy for the targeting 587 
construct.  ES cells containing the recombinant Pank2 at the correct locus were identified by 588 
Southern blotting analysis using the BamHI restriction enzyme, B, and a 722 bp probe outside the 589 
targeted portion.  LoxP sites (?) allowed for the cre-mediated deletion of the selection cassette 590 
and exon 3.  (B) Genotyping was accomplished by PCR using primers F, R and R2 as described 591 
under “Materials and Methods.”  A 618 and 526 bp products indicated the presence of a wild type 592 
allele and knockout allele, respectively. 593 
 594 
FIG. 2.  PanK isozyme expression in murine and human tissues.  (A and B) The abundance 595 
of murine (A) or human (B) PanK isoform mRNAs was determined in brain, testes and liver by real 596 
time RT-PCR.  (C and D) The same analysis was conducted on mRNA from specific regions of the 597 
murine (C) and human (D) brain.  PanK2 is highly abundant in mouse testes and human brain.  All 598 
RNA samples were purchased with the exception of murine RNA from whole brain, testes and liver 599 
and caudate nucleus that was extracted from 2-3 wild type mice as described under “Materials and 600 
Methods.”  Individual samples were analyzed in triplicate, averaged and plotted relative to mouse 601 
or human glyceraldehyde-3-phosphate dehydrogenase mRNA.  Data obtained from different mice 602 
were then further averaged.  All data are plotted as mean ± the standard error.   603 
 604 
FIG. 3.  Measurement of total CoA in murine whole tissues and liver fractions.  (A) Total 605 
CoA levels were determined in brain, liver and testes obtained from wild type (black bars) and 606 
Pank2 knockout (white bars) mice as described under Materials and Methods.”  (B) Mitochondrial 607 
and cytosolic fractions were isolated from the livers of wild type (black bars) and Pank2 knockout 608 
(white bars) mice and the total CoA measured.  No significant difference was observed CoA levels 609 
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of whole tissues or liver fractions from wild type and Pank2-deficient mice.  The data represent the 610 
average of three independent experiments ± the standard error. 611 
 612 
FIG. 4.  Regulatory properties of mPanK2 and hPank2.  (A) Acetyl-CoA inhibited both 613 
mPanK2 (?) and the mature form of hPanK2 (41) (?) with similar IC50 of 62.5 and 125 nM, 614 
respectively.  (B) Inhibition by acetyl-CoA was released by the addition of palmitoylcarnitine.  The 615 
enzymes were incubated with fixed concentrations of acetyl-CoA corresponding to the respective 616 
IC50s and with increasing amounts of the activator.  The data represent the average of two 617 
independent experiments ± the standard error. 618 
 619 
FIG. 5.  Analysis of the acylcarnitine pool in mouse tissues.  The composition of the 620 
acylcarnitine pool present in the brain (A) and liver (B) of wild type and Pank2 knockout mice was 621 
determined by electrospray mass spectroscopy as described under “Materials and Methods.”  The 622 
brain and liver acylcarnitine pools showed significantly different compositions, with long-chain 623 
acylcarnitines, known activators of PanK2, were abundant in the brain but not in the liver.  Loss of 624 
mPanK2 did not cause a remodeling of the acylcarnitine pool.   625 
 626 
FIG. 6.  DNA level sequence similarity of the 5-untranslated regions and exon 1 of six 627 
mammals. Genomic DNA sequences were aligned using the VISTA set of tools for comparative 628 
genomics and using human PANK2 as the reference sequence.  Black arrows indicate the 629 
positions of the predicted start codons in the corresponding organisms.  The region corresponding 630 
to the human mitochondrial targeting signal has been shadowed and the positions of the 631 
mitochondrial processing peptidase cleavage sites (19) are indicated by the scissor symbol at the 632 
top. 633 
 634 
FIG. 7.  Subcellular localization of mPanK2 and hPanK2.  (A-C) Stably transfected HET 293 635 
cells expressing mPanK2, (E-G) the mitochondrial precursor form of hPanK2 (41) or containing (D 636 
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and H) the empty vector were cultured and prepared for immunofluorescence as described under 637 
‘Materials and Methods’.  (A and D) Cells were incubated with MitoTracker red CMXRos and with 638 
specific antibodies against (B and F) mPanK2 or (E and H) hPanK2, followed by incubation with 639 
anti-rabbit IgG conjugated to Alexa Fluor 488 green; nuclei were stained with DAPI (blue).  Panels 640 
C and D show the merged images for mPanK2 and empty vector, respectively; panels G and H 641 
show the merged images for hPanK2 and empty vector, respectively.  hPanK2 localized to the 642 
mitochondria, while mPanK2 was found in the cytosol. 643 
 644 
FIG. 8.  Cytosolic localization of mPanK2 confirmed by activity assays and western blotting 645 
analysis.  (A) Western blot using 200 μg of brain mitochondrial and cytosolic fraction protein from 646 
wild type and Pank2 knockout mice and the specific mPanK2 antibody.  195 μg of cytosolic protein 647 
from knockout mice were mixed with 5 μg of lysate protein from stably transfected HET 293 cells 648 
expressing mPanK2 and used as a control.  (B) The total PanK activity was measured in liver (?, 649 
?) and brain (?, ?) cytosolic fractions obtained from wild type (?, ?) and PanK2 knockout (?, ?) 650 
mice as described under ‘Materials and Methods’.  Cytosolic fractions from knockout mice showed 651 
a significantly lower activity than those from wild type, consistent with the absence of mPanK2 in 652 
this cellular compartment.   653 
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